Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR01Clinical trial: Optional / allowed

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PAS-25-073

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Nov 5, 2027
Letter of intent
Mechanism
R01
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Jan 8, 2025
Total funding
Clinical trial
Optional / allowed
Established investigatorHigher educationNonprofitGovernmentSmall businessForeign entities

Funding context

16%of applications funded

Based on FY2024 NIH (all institutes) R01 applications (5,385 of 33,139 applications awarded).

Institute-specific data wasn’t available — showing the NIH-wide rate for this mechanism.

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIH-wide R01, all institutes.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Description

This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.